JBIO vs ARDX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 16, 2026

JBIO

59.2
AI Score
VS
JBIO Wins

ARDX

51.2
AI Score

Investment Advisor Scores

JBIO

59score
Recommendation
HOLD

ARDX

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric JBIO ARDX Winner
Forward P/E 0 40.6504 Tie
PEG Ratio 0 -0.08 Tie
Revenue Growth 0.0% 27.5% ARDX
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 59.2/100 51.2/100 JBIO
Profit Margin 0.0% -13.6% JBIO
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

JBIO 1M: -11.0% · 3M: -21.0% ARDX 1M: -5.5% · 3M: -27.6%

Current Technical Phase

JBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.3%), weak momentum, RSI 42

RSI (14): 42.1 · Price: $19.15

ARDX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.7%), weak momentum, RSI 38

RSI (14): 38.4 · Price: $4.98

Fundamentals Snapshot

Metric JBIO ARDX
Market Cap
Forward P/E -8.7 9.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.3%
Gross Margin 0.7%
Operating Margin 0.0% -0.3%
EPS -2.72 -0.24
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, JBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.